Critical Appraisal of Cenobamate as Adjunctive Treatment of Focal Seizures in Adults
Sign Up to like & getrecommendations! Published in 2021 at "Neuropsychiatric Disease and Treatment"
DOI: 10.2147/ndt.s281490
Abstract: Abstract Cenobamate (CNB) is the latest antiseizure medication (ASM) authorized for the treatment of focal-onset seizures in adults. Although the precise mechanism of action of CNB is not yet fully understood, this drug inhibits the… read more here.
Keywords: drug; treatment; treatment focal; day ... See more keywords